Ligand · 2OO
2OO · 4-[1-(4-amino-1,3,5-triazin-2-yl)-2-(ethylamino)-1H-benzimidazol-6-yl]-2-methylbut-3-yn-2-ol
2OO, 4-[1-(4-amino-1,3,5-triazin-2-yl)-2-(ethylamino)-1H-benzimidazol-6-yl]-2-methylbut-3-yn-2-ol (C17 H19 N7 O, 337.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- 2OO
- Formula
- C17 H19 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
2OO in 2 structures; the first of them:
- 4O0Y · Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors · 2OO A601 · binds ILE327, GLY328, GLY330, VAL335, ALA348, LYS350, GLU366, VAL379 and 12 more
- 4O0Y · Back pocket flexibility provides group-II pak selectivity for type 1 kinase inhibitors · 2OO A601 · binds ILE327, GLY328, GLY330, VAL335, ALA348, LYS350, GLU366, VAL379 and 12 more
Residues it binds most
GLY 2, VAL 2, ALA 2, GLU 2, LEU 2, MET 2, PHE 2, ASP 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.